Subscription results of rights offering or equity-linked bonds (voluntary)

What happened

Penetrium Bioscience / Subscription Results of Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) / (2026.08.07) Subscription Results of Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) Subscription Results of Rights Offering or Equity-Linked Bonds (Voluntary Disclosure)

1. Type of securities: Registered common shares 2. Issuance method: Shareholder-allocation rights offering 3. Subscribers: Existing shareholders (holders of pre-emptive rights certificates) 4. Subscription date: 2026-08-06 5. Subscription results Planned number of shares to be issued (shares): 8,500,000 Subscribed shares for this subscription (shares): 7,737,661 Cumulative subscribed shares (shares): 7,737,661 Subscription rate: 91.03% 6. Method of handling fractional shares and forfeited shares 1. Forfeited shares arising after existing shareholders' over-subscription will be offered to the general public from August 10, 2026 to August 11, 2026. 2. Any remaining shares after the general public offering will be underwritten for its own account by the lead manager, Yuanta Securities Co., Ltd. 7. Other matters for reference in investment decisions 1. The above subscription date is the closing date of the existing shareholders' subscription. [Existing shareholders' subscription period: August 5 to August 6, 2026 (2 days)] 2. Details of subscription results: 1) Number of shares offered: 8,500,000 shares 2) Shares subscribed via pre-emptive rights certificates: 7,142,080 shares 3) Over-subscribed shares: 595,581 shares 4) Total subscribed: 7,737,661 shares 5) Forfeited shares: 762,339 shares 3. Future schedule 1) General public offering of forfeited shares: August 10 - 11, 2026 2) Refund and payment date: August 13, 2026 3) New share listing date: August 28, 2026 * Related disclosures 2026-08-03 Prospectus 2026-08-03 Securities registration statement (equity securities) 2026-08-03 Decision on rights offering (shareholder allocation with general public offering of forfeited shares) 2026-08-03 Final issue price determination for rights offering 2026-07-15 New listing of pre-emptive rights certificates (Penetrium Bioscience 10R) 2026-06-26 Securities registration statement (equity securities) 2026-06-26 First issue price determination for rights offering 2026-06-26 Decision on rights offering (shareholder allocation with general public offering of forfeited shares) 2026-06-11 Securities registration statement (equity securities) 2026-06-11 Decision on rights offering (shareholder allocation with general public offering of forfeited shares) 2026-05-27 Securities registration statement (equity securities) 2026-05-27 Decision on rights offering (shareholder allocation with general public offering of forfeited shares) 2026-04-30 Securities registration statement (equity securities) 2026-04-30 Decision on rights offering (shareholder allocation with general public offering of forfeited shares)